Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001774690-26-000006

Chief Financial Officer sold 4,578 shares at an average $32.14 ($147,145)

From the SEC's structured data for this filing

Trades in this filing

Leggett Thomas · Chief Financial Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-17 Sale : show line 1 in the form −1,274 $32.74 $41,710 13,476 D
2026-03-17 Sale : show line 2 in the form −922 $33.38 $30,772 12,554 D
2026-03-18 Sale : show line 3 in the form −2,173 $31.28 $67,980 10,381 D
2026-03-18 Sale : show line 4 in the form −172 $31.79 $5,468 10,209 D
2026-03-18 Sale : show line 5 in the form −37 $32.85 $1,215 10,172 D
Open-market sales · 4,578 sh · avg $32.14 · $147,145
Loading xslF345X06/form4-03192026_100335.xml…